Clinical Trial Update: A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci [Phase 2]

View source ↗

Summary

This Phase 2 trial tested AFN-12520000 for acute bacterial skin and skin structure infections due to Staphylococci and has completed, reporting on safety, toler…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections
• Burn Wound Infection
• Cellulitis
• Cutaneous Abscess
• Wound Infection

Drugs mentioned

• AFN-12520000

Snippet

Sponsor: Affinium Pharmaceuticals, Ltd | Conditions: Skin and Subcutaneous Tissue Bacterial Infections, Wound Infection | Phase 2 | Status: COMPLETED